Back

Gender differences in hypertension vs. diabetes cardiovascular mortality A CDC WONDER study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Interaction between hypertension and diabetes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Piyush Sajnani

University Hospitals Plymouth NHS Trust, Plymouth (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Rising mortality related to diabetes mellitus and hypertension: trends and disparities in the United States (1999-2023)
Doctor C. Ranasinghe (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Non-linear association between the triglyceride-glucose index and all-cause and cardiovascular mortality in diabetes mellitus patients with hypertension: a retrospective cohort study
Doctor Y. Zhao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Hypertension related vs diabetes related cardiovascular deaths which is the bigger killer? a USA mortality trend analysis using CDC WONDER
Doctor M. Khan (Newcastle-Upon-Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Factors associated with poor blood pressure control in type 2 diabetic hypertensive patients
Professor A. Bachir-Cherif (Blida, DZ)
Abstract Slides Video

Access the full session

Session thumbnail
Interaction between hypertension and diabetes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Rising mortality related to diabetes mellitus and hypertension: trends and disparities in the United States (1999-2023)
thumbnail
Congress Presentation
Hypertension related vs diabetes related cardiovascular deaths which is the bigger killer? a USA mortality trend analysis using CDC WONDER
thumbnail
Congress Presentation
Temporal trends of mortality in hypertensive females with aortic aneurysm versus aortic dissection: a retrospective analysis of perimenopausal and older cohorts (1999 - 2023)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources